We can read DNA, write in DNA, and also build with DNA. Once planned and encoded in the sequences of DNA molecules, the three-dimensional, extremely precise structures put themselves together. To bring this fabrication technology into real-world use, Prof. Dietz and his team are exploring three main directions: Next-generation biochips, cancer therapy, and antiviral therapy, supported by the Federal Agency of Disruptive Innovation, SPRIND.
Listen to the talks at the Digital Life Design (DLD) conference in Munich from January 13 to find out more in the video below.
At this point content of an external provider (source: www.youtube-nocookies.com) is integrated. When displaying, data may be transferred to third parties or cookies may be stored, therefore your consent is required.
You can find more information and the possibility to revoke your consent at our privacy statement.
More Information
Hendrik Dietz is Professor of Biomolecular Nanotechnology at the Technical University of Munich. He has founded several biotech start-ups (tilibit nanosystems, capsitec, Plectonic Biotech) with some of his former students and coworkers. Dietz runs research laboratories at the Center for Nanoscience and Nanotechnology and at the Munich Institute of Biomedical Engineering (MIBE) at TUM.
The Digital-Life-Design (DLD) conference took place in Munich from January 12 -14, 2023.
News about spin-off Plectonic (November 2022): Nanoswitches for tumor targeting
Contact Media Relations
Carolin Lerch
carolin.lerch(at)tum.de
MIBE Media Relations:
presse@bioengineering.tum.de
Scientific Contact
Prof. Dr. Hendrik Dietz
Technical University of Munich
Chair of Biomolecular Nanotechnology
Tel: +49 89 289 11615
dietz(at)tum.de